171 related articles for article (PubMed ID: 35655404)
1. Inflammatory leiomyosarcoma/rhabdomyoblastic tumor: A report of two cases with novel genetic findings.
Sukhanova M; Obeidin F; Streich L; Alexiev BA
Genes Chromosomes Cancer; 2022 Nov; 61(11):653-661. PubMed ID: 35655404
[TBL] [Abstract][Full Text] [Related]
2. "Inflammatory Leiomyosarcoma" and "Histiocyte-rich Rhabdomyoblastic Tumor": a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as "Inflammatory Rhabdomyoblastic Tumor".
Cloutier JM; Charville GW; Mertens F; Sukov W; Fritchie K; Perry KD; Edgar M; Rowsey RA; Folpe AL
Mod Pathol; 2021 Apr; 34(4):758-769. PubMed ID: 33318583
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary "Inflammatory Leiomyosarcomas" Are Indolent Tumors With Diploid Genomes and No Convincing Rhabdomyoblastic Differentiation.
Kao YC; Kuo CT; Kuo PY; Huang HY; Lu TP; Hsieh TH; Fletcher CDM; Lee JC
Am J Surg Pathol; 2022 Mar; 46(3):424-433. PubMed ID: 35175969
[TBL] [Abstract][Full Text] [Related]
4. Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma.
Nord KH; Paulsson K; Veerla S; Wejde J; Brosjö O; Mandahl N; Mertens F
Neoplasia; 2012 Sep; 14(9):807-12. PubMed ID: 23019412
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.
Odate T; Satomi K; Kubo T; Matsushita Y; Ueno T; Kurose A; Shomori K; Nakai T; Watanabe R; Segawa K; Ohshika S; Miyake N; Kudo S; Shimoi T; Kobayashi E; Komiyama M; Yoshimoto S; Nakatani F; Kawai A; Yatabe Y; Kohsaka S; Ichimura K; Ichikawa H; Yoshida A
Mod Pathol; 2024 Jan; 37(1):100359. PubMed ID: 37871654
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor.
Michal M; Rubin BP; Kazakov DV; Michalová K; Šteiner P; Grossmann P; Hájková V; Martínek P; Švajdler M; Agaimy A; Hadravský L; Kalmykova AV; Konishi E; Heidenreich F; Michal M
Virchows Arch; 2020 Aug; 477(2):219-230. PubMed ID: 32078043
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Rhabdomyoblastic Tumor: From a Nebulous Smooth Muscle Neoplasm to a Novel Skeletal Muscle Tumor Subtype.
Michal M
Surg Pathol Clin; 2024 Mar; 17(1):65-76. PubMed ID: 38278608
[TBL] [Abstract][Full Text] [Related]
8. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
Malander S; Rambech E; Kristoffersson U; Halvarsson B; Ridderheim M; Borg A; Nilbert M
Gynecol Oncol; 2006 May; 101(2):238-43. PubMed ID: 16360201
[TBL] [Abstract][Full Text] [Related]
9. Fine-needle aspiration biopsy diagnosis of histiocyte-rich rhabdomyoblastic tumor (inflammatory leiomyosarcoma): A case report.
McHugh KE; Kilpatrick SE
Diagn Cytopathol; 2023 Apr; 51(4):E109-E112. PubMed ID: 36519516
[TBL] [Abstract][Full Text] [Related]
10. Histiocyte-rich rhabdomyoblastic tumor: a report of two cases and a review of the differential diagnoses.
Bourgeau M; Martinez AP
Virchows Arch; 2021 Feb; 478(2):367-373. PubMed ID: 32514584
[TBL] [Abstract][Full Text] [Related]
11. Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.
Middeldorp A; van Eijk R; Oosting J; Forte GI; van Puijenbroek M; van Nieuwenhuizen M; Corver WE; Ruano D; Caldes T; Wijnen J; Morreau H; van Wezel T
Int J Cancer; 2012 Feb; 130(4):837-46. PubMed ID: 21445971
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature.
Arbajian E; Köster J; Vult von Steyern F; Mertens F
Mod Pathol; 2018 Jan; 31(1):93-100. PubMed ID: 28884746
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic aberrations and heterogeneity of mutations in repeat-containing genes in a colon carcinoma from a patient with hereditary nonpolyposis colorectal cancer.
Planck M; Halvarsson B; Pålsson E; Hallén M; Ekelund M; Pålsson B; Baldetorp B; Nilbert M
Cancer Genet Cytogenet; 2002 Apr; 134(1):46-54. PubMed ID: 11996796
[TBL] [Abstract][Full Text] [Related]
14. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features.
Christacos NC; Quade BJ; Dal Cin P; Morton CC
Genes Chromosomes Cancer; 2006 Mar; 45(3):304-12. PubMed ID: 16320247
[TBL] [Abstract][Full Text] [Related]
15. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
Agaimy A; Thiel F; Hartmann A; Fukunaga M
Ann Diagn Pathol; 2015 Oct; 19(5):283-7. PubMed ID: 26123103
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma.
Oda Y; Miyajima K; Kawaguchi K; Tamiya S; Oshiro Y; Hachitanda Y; Oya M; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2001 Aug; 25(8):1030-8. PubMed ID: 11474287
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of mutations in leiomyosarcomas identified by clinical targeted next-generation sequencing.
Lee PJ; Yoo NS; Hagemann IS; Pfeifer JD; Cottrell CE; Abel HJ; Duncavage EJ
Exp Mol Pathol; 2017 Feb; 102(1):156-161. PubMed ID: 28093192
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor.
Plaschke J; Linnebacher M; Kloor M; Gebert J; Cremer FW; Tinschert S; Aust DE; von Knebel Doeberitz M; Schackert HK
Eur J Hum Genet; 2006 May; 14(5):561-6. PubMed ID: 16418736
[TBL] [Abstract][Full Text] [Related]
19. Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type.
David MP; Venkatramani R; Lopez-Terrada DH; Roy A; Patil N; Fisher KE
Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 30275002
[TBL] [Abstract][Full Text] [Related]
20. Recent updates in thoracic SMARCA4-deficient undifferentiated tumor.
Nambirajan A; Jain D
Semin Diagn Pathol; 2021 Sep; 38(5):83-89. PubMed ID: 34147303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
